Clinical Characteristics of Study Samples.

<p>Values are presented as trait mean and standard deviation.</p

GWAS + Replication, Validation and Overall <i>P</i>-values for susceptibility loci identified from the Overall meta-analysis (P<2.5×10⁻⁵).

<p>SNPs are ordered by chromosome and position (NCBI Build 36.1, hg18) with the major/minor alleles (positive strand) and corresponding gene (underlined) or nearest annotated genes (+/−500 kb). For each phase of the study, GWAS + Replication, Validation and Overall (GWAS+Replication+T2DM+IRAS+IRASFS) analyses, the minor allele frequency (MAF) in controls, additive <i>P</i>-value and odds ratio (OR) with associated 95% confidence interval (CI) with respect to the minor allele is listed.</p

Study Design.

<p>Study Design.</p

Genome-Wide Association Study Results.

<p>Results are adjusted for admixture using PC1 as a covariate in the analysis. <i>P</i>-values are shown under the additive model. The blue line at -log₁₀(<i>P</i>-value) = 3 represents an additive <i>P</i>-value = 0.001 and the red line at -log₁₀(<i>P</i>-value) = 5 represents a <i>P</i>-value = 1.0×10⁻⁵.</p